Sinopharm
1099.HK
#2014
Rank
โ‚น687.41 B
Marketcap
โ‚น220.28
Share price
1.24%
Change (1 day)
-2.85%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.354 Trillion. an increase over the revenue in the year 2022 that were of โ‚น6.976 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 โ‚น7.354 T5.42%
2022 โ‚น6.976 T-2.1%
2021โ‚น7.125 T16.85%
2020โ‚น6.098 T14.95%
2019โ‚น5.305 T21.52%
2018โ‚น4.365 T5.93%
2017โ‚น4.121 T27.22%
2016โ‚น3.239 T5.37%
2015โ‚น3.074 T9.14%
2014โ‚น2.816 T17.22%
2013โ‚น2.402 T25.94%
2012โ‚น1.907 T34.61%
2011โ‚น1.417 T55.34%
2010โ‚น912.43 B35.79%
2009โ‚น671.95 B37.56%
2008โ‚น488.49 B31.43%
2007โ‚น371.68 B40.26%
2006โ‚น264.99 B